RYTM
Rhythm Pharmaceuticals Inc Earnings
$65.77
Earnings Summary
Revenue | $32.7Mn |
Net Profits | $-49.5Mn |
Net Profit Margins | -151.35% |
Rhythm Pharmaceuticals Inc’s revenue jumped 25.94% since last year same period to $32.7Mn in the Q1 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -21.82% fall in its revenue since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit jumped 64.99% since last year same period to $-49.5Mn in the Q1 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -14.34% fall in its net profits since last 3-months.
Rhythm Pharmaceuticals Inc’s net profit margin jumped 72.2% since last year same period to -151.35% in the Q1 2025. On a quarterly growth basis, Rhythm Pharmaceuticals Inc has generated -46.24% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.65 |
EPS Estimate Current Year | -0.65 |
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.65 - a 69.71% jump from last quarter’s estimates.
Rhythm Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.65.
Key Ratios
Earning Per Share (EPS) | 0 |
Rhythm Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Rhythm Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-08-05 | -0.65 | 0 | 100% |
2025-05-07 | -2.16 | -0.81 | 62.5% |
